Literature DB >> 33482625

Gout in China, 1990-2017: the Global Burden of Disease Study 2017.

Y M Tang1, L Zhang1, S Z Zhu1, J J Pan1, S H Zhou1, T J He1, Q Li2.   

Abstract

OBJECTIVE: The aim of the study was to estimate the gout burden and risk factors in China from 1990 to 2017. STUDY
DESIGN: The Global Burden of Disease (GBD) Study uses various analytical tools and a diverse set of data sources to generate comparable estimates of deaths and mortality rates broken down by age, sex, cause, year, and geography.
METHODS: We used the results from the GBD Study 2017 to compare disability-adjusted life years (DALYs), prevalence, incidence, and risk factors of gout in China. The median of the percentage change and 95% uncertainty intervals were determined for the period between 1990 and 2017.
RESULTS: The age-standardized DALY rate, prevalence, and incidence increased 6.92%, 6.88%, and 6.16%, respectively, in China from 1990 to 2017. Although the rates of gout both globally and in China were increasing, the range of change for males in China was larger than that of the global level. All risk factors combined accounted for 30.04% of gout DALYs in 2017. The leading risk factors for gout DALYs were high body mass index and impaired kidney function, and the proportion of high body mass index increased significantly from 10.67% to 24.31%, whereas the proportion of impaired kidney function remained basically unchanged.
CONCLUSIONS: The age-standardized DALY rate, prevalence, and incidence in China have increased progressively since 1990. Increasing attention on body weight management should be prioritized for controlling the rising prevalence of gout in the young and middle-aged population.
Copyright © 2020 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disability-adjusted life years; Global Burden of Disease; Gout; Incidence; Prevalence; Risk factors

Mesh:

Year:  2021        PMID: 33482625     DOI: 10.1016/j.puhe.2020.06.029

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  3 in total

1.  MicroRNA-223 Suppresses IL-1β and TNF-α Production in Gouty Inflammation by Targeting the NLRP3 Inflammasome.

Authors:  Quan-Bo Zhang; Dan Zhu; Fei Dai; Yu-Qin Huang; Jian-Xiong Zheng; Yi-Ping Tang; Zeng-Rong Dong; Xia Liao; Yu-Feng Qing
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

2.  Construction of lncRNA-miRNA-mRNA network based on ceRNA mechanism reveals the function of lncRNA in the pathogenesis of gout.

Authors:  Feng Chen; Xiaoyun Zhang; Yueping Chen; Yuan Chai; Xiao Jiang; Huanan Li
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

Review 3.  The Role of the "Anti-Inflammatory" Couple for the Management of Hyperuricemia With Deposition.

Authors:  Andrea Sansone; Yacov Reisman; Suada Meto; Susanna Dolci; Emmanuele A Jannini
Journal:  Sex Med       Date:  2022-09-07       Impact factor: 2.523

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.